Americans face a challenge of our own making on the path to herd immunity: our failure to properly consider the needs of children.
While we can celebrate the fact that more than 200 million doses of COVID-19 vaccines have been administered in the U.S., few of them, outside of clinical trials, have gone into the arms of children younger than 16. That’s why we need to recalibrate our expectations—and redouble our efforts—so that the tens of millions of children in this country are kept safe.
The above is an excerpt of a piece originally published in USA Today.
Media Resources & News
Visit our press room to find out who our key points of contact are, including supporting research, expertise, and multimedia assets needed for publication.